These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 30390797

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Applications of Biophysics in High-Throughput Screening Hit Validation.
    Genick CC, Barlier D, Monna D, Brunner R, Bé C, Scheufler C, Ottl J.
    J Biomol Screen; 2014 Jun; 19(5):707-14. PubMed ID: 24695619
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. waveRAPID-A Robust Assay for High-Throughput Kinetic Screens with the Creoptix WAVEsystem.
    Kartal Ö, Andres F, Lai MP, Nehme R, Cottier K.
    SLAS Discov; 2021 Sep; 26(8):995-1003. PubMed ID: 34049465
    [Abstract] [Full Text] [Related]

  • 9. Biophysical screening for the discovery of small-molecule ligands.
    Ciulli A.
    Methods Mol Biol; 2013 Sep; 1008():357-88. PubMed ID: 23729259
    [Abstract] [Full Text] [Related]

  • 10. Combining biophysical screening and X-ray crystallography for fragment-based drug discovery.
    Hennig M, Ruf A, Huber W.
    Top Curr Chem; 2012 Sep; 317():115-43. PubMed ID: 21837555
    [Abstract] [Full Text] [Related]

  • 11. High-throughput differential scanning fluorimetry (DSF) and cellular thermal shift assays (CETSA): Shifting from manual to automated screening.
    Hansel CS, Lanne A, Rowlands H, Shaw J, Collier MJ, Plant H.
    SLAS Technol; 2023 Dec; 28(6):411-415. PubMed ID: 37598756
    [Abstract] [Full Text] [Related]

  • 12. Novel trends in high-throughput screening.
    Mayr LM, Bojanic D.
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [Abstract] [Full Text] [Related]

  • 13. From experimental design to validated hits a comprehensive walk-through of fragment lead identification using surface plasmon resonance.
    Giannetti AM.
    Methods Enzymol; 2011 Oct; 493():169-218. PubMed ID: 21371592
    [Abstract] [Full Text] [Related]

  • 14. Biophysics: for HTS hit validation, chemical lead optimization, and beyond.
    Genick CC, Wright SK.
    Expert Opin Drug Discov; 2017 Sep; 12(9):897-907. PubMed ID: 28658992
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mass spectrometry for fragment screening.
    Chan DS, Whitehouse AJ, Coyne AG, Abell C.
    Essays Biochem; 2017 Nov 08; 61(5):465-473. PubMed ID: 28986384
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Biophysics in drug discovery: impact, challenges and opportunities.
    Renaud JP, Chung CW, Danielson UH, Egner U, Hennig M, Hubbard RE, Nar H.
    Nat Rev Drug Discov; 2016 Oct 08; 15(10):679-98. PubMed ID: 27516170
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.